Drug intelligence / Profile preview

Ambiotech Bio-Pulsed Exosome

Development stage
Preclinical
Lead developer
Ascension Medical Biotechnology
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical
01

Overview

Ambiotech's Bio-Pulsed Exosome therapy is an extracellular vesicle (EV)-based biologic modality currently in preclinical development for the treatment of degenerative arthritis (osteoarthritis). Developed by Ascension Medical Biotechnology (Ambiotech), the therapy utilizes proprietary 'Bio-Pulsed' technology to produce functionally induced exosomes derived from SPF chicken embryonic mesenchymal cells. These exosomes are designed to deliver bioactive growth factors and anti-inflammatory agents to the joint environment, promoting tissue repair and reducing inflammation. The manufacturing process employs high-efficiency ultra-purification technology to ensure high purity (up to 99.99%) and potency of the therapeutic vesicles. The therapy is being developed in collaboration with various medical institutions and universities.

Other names
Bio-Pulsed ExosomeChicken Embryonic Mesenchymal Cell-Derived Extracellular VesiclesAscension Medical Biotechnology Bio-Pulsed Exosome

Beyond the preview

Go deeper on Ambiotech Bio-Pulsed Exosome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ambiotech Bio-Pulsed Exosome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call